The size of the Latin American stem cell assay market is estimated to be growing at a CAGR of 20.1% during the forecast period. The market is estimated to value USD 281.64 million by 2027 from USD 112.71 million in 2022.
Stem cells can remarkably differentiate into various cell types and are involved in the body's internal repair mechanism all over Latin America.
The expanding biotechnology sector and the rising burden of diseases such as cancer, diabetes, and others are predicted to be the key drivers of market expansion throughout the forecast period.
One of the most critical aspects is stem cell assays, which evaluate living cells biochemical and cellular activity based on parameters such as shape, size, and others. Stem cell tests are commonly employed in pharmaceutical development due to these qualities.
Diabetic patients in Latin America are expected to number over 42 million in 2019. Diabetes, according to the World Health Organization, will be the seventh leading cause of death in Latin America by 2030. Moreover, higher healthcare spending and government support will boost the market during the forecast period.
An essential factor is that stem cells' real potential can only be determined after being harvested. Backdrop analysis, which gives a quantitative or qualitative evaluation of stem cells, is referred to as the retrospective approach. The Latin American stem cell assay market will benefit from advancements in embryonic and adult stem cell assays.
Constraints such as strict government laws, high procedural costs, and a lack of expertise and qualified labor would impede market expansion during the predicted period.
A scarcity of experienced professionals hamper the market's expansion to analyze stem cells, the high cost of instruments and stem cell-based therapies, and stringent intellectual property rights.
However, suppose stem cells are not developed successfully into the required adult cell type. In that case, transplanted stem cells may revert to teratoma cells, resulting in a teratoma, and transplant rejection is always a risk. As a result, the market for stem cell assays is expected to be stifled.
This research report on the Latin America Stem Cell Assay Market has been segmented and sub-segmented into the following categories.
By Assay Type:
By End User:
Geographically, the Latin America stem cell assay market accounts for a small portion of the global market and is predicted to grow due to increased awareness and rising healthcare expenditures in the region. In addition, the adoption of stem cell assay in the area and the introduction of new technologies are driving increasing demand for stem cell assay.
The regional market is expanding as demand for drug testing rises, and governmental and private research institutes conduct more research. Another factor driving the industry is the rise in chronic illnesses.
The Mexico stem cell assay market is expected to reach a healthy CAGR due to the increased government funding for research and development aids market expansion, and the growing biotechnology sector and significant patient population are driving the market in this region.
The Brazil stem cell assay market is the second-largest market in the Latin America region due to the biotechnology research and development, and the need for stem cell assay is expected to grow due to greater acceptance of new technologies and a large patient population suffering from diseases such as diabetes, cancer, and others. In addition, market growth is aided by increased healthcare spending and established economies in the region.
The Argentina stem cell assay market encourages the region's growth, as it has a well-established healthcare sector and significant healthcare expenditures.
KEY MARKET PLAYERS
Notable companies operating the Latin America Stem Cell Assay Market profiled in the report are Thermo Fisher Scientific Inc., Bio-Techne Corporation, GE Healthcare, Bio-Rad Laboratories, Inc., Stem cell Technologies Inc., Merck KGaA, Promega Corporation, Cellular Dynamics International Inc., Hemogenix, and Cell Biolabs Inc.,
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Assay Type
5.1.2 Cell Viability & Toxicity Assays
5.1.3 Cell Identification Assays
5.1.4 Cell Differentiation Assays
5.1.5 Isolation/Purification Assays
5.1.6 Cell Proliferation Assays
5.1.7 Cell Apoptosis Assays
5.1.8 Cell Function Assays
5.1.9 Y-o-Y Growth Analysis, By Assay Type
5.1.10 Market Attractiveness Analysis, By Assay Type
5.1.11 Market Share Analysis, By Assay Type
5.2.2 Technology Roadmap
5.2.3 Micro Fabricated Assisted Technology
126.96.36.199 Microfluidics Based Cell Trap Technologies
5.2.4 Technology in Development
5.2.5 Y-o-Y Growth Analysis, By Technology
5.2.6 Market Attractiveness Analysis, By Technology
5.2.7 Market Share Analysis, By Technology
5.3.2 Adult Stem Cell Kits
188.8.131.52 Induced Pluripotent Stem Cell Kits
184.108.40.206 Mesenchymal Stem Cell Kits
220.127.116.11 Neuronal Stem Cells Kits
18.104.22.168 Umbilical Cord Stem Cells
22.214.171.124 Hematopoietic Stem Cell Kits
5.3.3 Human Embryonic Stem Cells Kits
5.3.4 Y-o-Y Growth Analysis, By Kits
5.3.5 Market Attractiveness Analysis, By Kits
5.3.6 Market Share Analysis, By Kits
126.96.36.199 Micro Electrode Arrays
188.8.131.52 Cell Imaging Systems
184.108.40.206 Automated Cell Counter
220.127.116.11 Flow Cytometer
5.4.3 Detection Kits
18.104.22.168 Immuno Histochemistry Kits
5.4.4 Y-o-Y Growth Analysis, By Product
5.4.5 Market Attractiveness Analysis, By Product
5.4.6 Market Share Analysis, By Product
5.5.2 Regenerative Medicine & Therapy Development
22.214.171.124 Orthopedic & Musculoskeletal Spine
126.96.36.199 Central Nervous System
5.5.3 Drug Discovery and Development
5.5.4 Clinical Research
5.6 End User
5.6.2 Research Institutes
5.6.3 Industry Research
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Assay Type
220.127.116.11 By Technology
18.104.22.168 By Kits
22.214.171.124 By Product
126.96.36.199 By Application
188.8.131.52 By End User
6.1.4 Market Attractiveness Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Assay Type
18.104.22.168 By Technology
22.214.171.124 By Kits
126.96.36.199 By Product
188.8.131.52 By Application
184.108.40.206 By End User
6.1.5 Market Share Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Assay Type
22.214.171.124 By Technology
126.96.36.199 By Kits
188.8.131.52 By Product
184.108.40.206 By Application
220.127.116.11 By End User
6.4 Rest of Latin America
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Thermo Fisher Scientific Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bio-Techne Corporation
8.3 STEMCELL Technologies Inc.
8.4 Promega Corporation
8.5 GE Healthcare
8.6 Bio-Rad Laboratories, Inc.
8.7 Merck KGaA
8.8 Cellular Dynamics International Inc.
8.10 Cell Biolabs Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.